Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Baudax Bio, Inc. (BXRX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-K10-K
Net income  -58.8-19.8-76.1-32.6-73.7
Depreciation and amortization   [+]   0.50.4
Stock-based compensation     5.54.6
Change in working capital   [+]17.63.315.7-2.20.4
Other operating activities  13.4-32.816.3-21.28.5
Cash from operations  -27.8-49.3-44.1-50.0-59.8
   
Capital expenditures  0.00.20.6-1.3-3.4
Acquisitions     -0.2-0.1
Purchases of short-term investments   19.6   
Other cash from investing  0.0-20.0-1.3  
Cash from investing  0.0-0.2-0.6-1.5-3.5
   
Issuance of common stock, net  18.6 23.1  
Other cash from financing  -1.535.034.269.363.2
Cash from financing  17.235.057.369.363.2
   
Free cash flow  -27.8-49.1-43.4-51.4-63.1
        Per share (diluted)  ($83.75)($896.40)($81.52)($5.49)($6.75)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy